Biotech by dividend yield
Dividends paid over the last twelve months as a share of today's price.
Amgen leads the 20 biotech ranked by dividend yield, at 2.17%, ahead of Gilead Sciences (1.91%) and Bio-Techne (0.33%). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Amgen2.17%
- Median
- 0.00%
- Combined market value
- TRY 42.31T
- Countries
- 5
- Not ranked
- 4no dividend yield on file
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Dividend yield ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | 2.17% | TRY 12.19T | TRY 22,531.78 | 2.44% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | 1.91% | TRY 10.54T | TRY 8,499.22 | 1.02% down | 33% up | ||
| 3 | Bio-TechneTECH · Health Care | 0.33% | TRY 576.2B | TRY 3,667.96 | 0.13% up | 26% up | ||
| 4 | ModernaMRNA · Health Care | 0.00% | TRY 4.1T | TRY 10,121.76 | 2.96% down | 755% up | ||
| 5 | BiogenBIIB · Health Care | 0.00% | TRY 1.86T | TRY 12,581.26 | 0.53% down | 49% up | ||
| 6 | Revolution MedicinesRVMD · Health Care | 0.00% | TRY 1.75T | TRY 8,069.76 | 1.65% down | 131% up | ||
| 7 | ExelixisEXEL · Health Care | 0.00% | TRY 848.2B | TRY 3,476.05 | 0.61% up | 63% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | 0.00% | TRY 829.1B | TRY 8,191.06 | 2.12% down | 20% up | ||
| 9 | Halozyme TherapeuticsHALO · Health Care | 0.00% | TRY 557.4B | TRY 4,889.01 | 1.01% up | 37% up | ||
| 10 | RepligenRGEN · Health Care | 0.00% | TRY 549.9B | TRY 8,602.87 | 5.17% up | 5% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | 0.00% | TRY 519.7B | TRY 6,087.63 | 0.67% down | 87% up | ||
| 12 | VaxcytePCVX · Health Care | 0.00% | TRY 470.4B | TRY 2,971.44 | 0.82% down | 22% up | ||
| 13 | Krystal BiotechKRYS · Health Care | 0.00% | TRY 461.2B | TRY 15,562.78 | 3.35% up | 46% up | ||
| 14 | Twist BioscienceTWST · Health Care | 0.00% | TRY 395.3B | TRY 5,797.62 | 2.63% up | 340% up | ||
| 15 | CG OncologyCGON · Health Care | 0.00% | TRY 358.5B | TRY 4,014.20 | 0.82% up | 85% up | ||
| 16 | ImmunityBioIBRX · Health Care | 0.00% | TRY 354.1B | TRY 332.88 | 5.43% up | 193% up | ||
| 17 | ImmunovantIMVT · Health Care | 0.00% | TRY 351.1B | TRY 1,696.41 | 1.28% up | 43% up | ||
| 18 | Kodiak SciencesKOD · Health Care | 0.00% | TRY 317.4B | TRY 4,852.95 | 0.60% down | 396% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | 0.00% | TRY 291.2B | TRY 2,387.14 | 4.99% up | 14% up | ||
| 20 | Adaptive BiotechnologiesADPT · Health Care | 0.00% | TRY 229.5B | TRY 1,417.76 | 1.33% down | 88% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4360 TRY). 4 companies have no dividend yield on file and are not ranked here.
Questions and answers
Which biotech rank first by dividend yield?
Amgen (2.17%), Gilead Sciences (1.91%) and Bio-Techne (0.33%) are the top three of the 20 biotech ranked by dividend yield as of 18 Nov 2026, 16:15 UTC.
How many biotech are in this ranking?
20 are ranked by dividend yield. 4 more have no dividend yield on file and are left out rather than ranked at zero.
What are these biotech worth together?
The 20 biotech ranked by dividend yield have a combined market value of TRY 42.31T as of 18 Nov 2026, 16:15 UTC.
What does ranking by dividend yield measure?
Dividends paid over the last twelve months as a share of today's price.
Learn how this ranking works
All markets guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Biotech by dividend yield”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=dividend-yield
Underlying data: Yahoo Finance; SEC EDGAR.